tiprankstipranks
Trending News
More News >
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market

Giant Biogene Holding Co. Ltd. (2367) Income Statement

Compare
2 Followers

Giant Biogene Holding Co. Ltd. Income Statement

Last quarter (Q2 2024), Giant Biogene Holding Co. Ltd.'s total revenue was ¥2.54B, an increase of 157.94% from the same quarter last year. In Q2, Giant Biogene Holding Co. Ltd.'s net income was ¥983.16M. See Giant Biogene Holding Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 5.54B¥ 3.52B¥ 2.36B¥ 1.55B¥ 1.19B
Gross Profit
¥ 4.55B¥ 2.95B¥ 2.00B¥ 1.35B¥ 1.01B
Operating Expenses
¥ 2.24B¥ 1.28B¥ 817.32M¥ 425.62M¥ 198.00M
Depreciation and Amortization
¥ 31.62M¥ 34.17M¥ 27.63M¥ 24.21M¥ 22.29M
EBITDA
¥ 2.31B¥ 1.78B¥ 1.21B¥ 938.78M¥ 674.10M
Operating Income
¥ 2.31B¥ 1.66B¥ 1.19B¥ 914.57M¥ 651.81M
Other Income/Expenses
¥ 149.12M¥ 80.22M¥ -876.00K¥ 41.25M¥ 168.49M
Pretax Income
¥ 2.46B¥ 1.75B¥ 1.18B¥ 972.92M¥ 973.24M
Net Income
¥ 2.06B¥ 1.45B¥ 1.00B¥ 828.13M¥ 826.45M
Per Share Metrics
Basic EPS
¥ 2.10¥ 1.48¥ 0.99¥ 0.84¥ 0.83
Diluted EPS
¥ 2.06¥ 1.48¥ 0.98¥ 0.84¥ 0.83
Weighted Average Shares Outstanding
1.00B 980.91M 976.00M 974.79M 991.61M
Weighted Average Shares Outstanding (Diluted)
1.00B 982.72M 1.02B 991.61M 991.61M
Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis